Early Health Technology Assessment during Nonalcoholic Steatohepatitis Drug Development: A Two-Round, Cross-Country, Multicriteria Decision Analysis

Background. The assessment of value along the clinical development of new biopharmaceutical compounds is a challenging task. Complex and uncertain evidence has to be analyzed, considering a multitude of value preferences from different stakeholders. Objective. To investigate the use of multicriteria...

Descripción completa

Detalles Bibliográficos
Autores principales: Angelis, Aris, Thursz, Mark, Ratziu, Vlad, O’Brien, Alastair, Serfaty, Lawrence, Canbay, Ali, Schiefke, Ingolf, Costa, Joao Bana e, Lecomte, Pascal, Kanavos, Panos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457462/
https://www.ncbi.nlm.nih.gov/pubmed/32845234
http://dx.doi.org/10.1177/0272989X20940672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457462/
https://www.ncbi.nlm.nih.gov/pubmed/32845234
http://dx.doi.org/10.1177/0272989X20940672

Ejemplares similares